Carlsmed (CARL) Cash & Current Investments (2024 - 2026)

Carlsmed (CARL) has reported Cash & Current Investments for 3 consecutive years, with $113.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments rose 237.48% year-over-year to $113.3 million; the trailing twelve-month figure through Jun 2026 stood at $113.3 million (up 237.48% YoY), and the FY2025 full-year result was $109.8 million, up 172.95% from the prior year.
• Cash & Current Investments slipped to $113.3 million in Q2 2026 per CARL's latest filing, from $121.1 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $121.1 million in Q1 2026 and bottomed at $33.6 million in Q2 2025.
• Historically, Cash & Current Investments has averaged $73.3 million across 3 years, with a median of $44.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Cash & Current Investments dropped 12.0% in 2025, then surged 237.48% in 2026.
• Over 3 years, Cash & Current Investments stood at $40.2 million in 2024, then surged by 172.95% to $109.8 million in 2025, then gained by 3.19% to $113.3 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $113.3 million, $121.1 million, and $109.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.